Global Dendritic Cell Cancer Vaccine Market Research Report 2023

Report ID: 1982616 | Published Date: Jan 2025 | No. of Page: 100 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Dendritic Cell Cancer Vaccine Market Overview
    1.1 Product Overview and Scope of Dendritic Cell Cancer Vaccine
    1.2 Dendritic Cell Cancer Vaccine Segment by Type
        1.2.1 Global Dendritic Cell Cancer Vaccine Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 CreaVax
        1.2.3 Sipuleucel-T (Provenge)
        1.2.4 Others
    1.3 Dendritic Cell Cancer Vaccine Segment by Application
        1.3.1 Global Dendritic Cell Cancer Vaccine Sales Comparison by Application: (2022-2028)
        1.3.2 Pediatrics
        1.3.3 Adults
    1.4 Global Dendritic Cell Cancer Vaccine Market Size Estimates and Forecasts
        1.4.1 Global Dendritic Cell Cancer Vaccine Revenue 2017-2028
        1.4.2 Global Dendritic Cell Cancer Vaccine Sales 2017-2028
        1.4.3 Dendritic Cell Cancer Vaccine Market Size by Region: 2017 Versus 2021 Versus 2028
2 Dendritic Cell Cancer Vaccine Market Competition by Manufacturers
    2.1 Global Dendritic Cell Cancer Vaccine Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Dendritic Cell Cancer Vaccine Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Dendritic Cell Cancer Vaccine Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Dendritic Cell Cancer Vaccine Manufacturing Sites, Area Served, Product Type
    2.5 Dendritic Cell Cancer Vaccine Market Competitive Situation and Trends
        2.5.1 Dendritic Cell Cancer Vaccine Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Dendritic Cell Cancer Vaccine Players Market Share by Revenue
        2.5.3 Global Dendritic Cell Cancer Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dendritic Cell Cancer Vaccine Retrospective Market Scenario by Region
    3.1 Global Dendritic Cell Cancer Vaccine Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Dendritic Cell Cancer Vaccine Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Dendritic Cell Cancer Vaccine Market Facts & Figures by Country
        3.3.1 North America Dendritic Cell Cancer Vaccine Sales by Country
        3.3.2 North America Dendritic Cell Cancer Vaccine Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Dendritic Cell Cancer Vaccine Market Facts & Figures by Country
        3.4.1 Europe Dendritic Cell Cancer Vaccine Sales by Country
        3.4.2 Europe Dendritic Cell Cancer Vaccine Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Dendritic Cell Cancer Vaccine Market Facts & Figures by Region
        3.5.1 Asia Pacific Dendritic Cell Cancer Vaccine Sales by Region
        3.5.2 Asia Pacific Dendritic Cell Cancer Vaccine Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Dendritic Cell Cancer Vaccine Market Facts & Figures by Country
        3.6.1 Latin America Dendritic Cell Cancer Vaccine Sales by Country
        3.6.2 Latin America Dendritic Cell Cancer Vaccine Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Dendritic Cell Cancer Vaccine Market Facts & Figures by Country
        3.7.1 Middle East and Africa Dendritic Cell Cancer Vaccine Sales by Country
        3.7.2 Middle East and Africa Dendritic Cell Cancer Vaccine Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Dendritic Cell Cancer Vaccine Historic Market Analysis by Type
    4.1 Global Dendritic Cell Cancer Vaccine Sales Market Share by Type (2017-2022)
    4.2 Global Dendritic Cell Cancer Vaccine Revenue Market Share by Type (2017-2022)
    4.3 Global Dendritic Cell Cancer Vaccine Price by Type (2017-2022)
5 Global Dendritic Cell Cancer Vaccine Historic Market Analysis by Application
    5.1 Global Dendritic Cell Cancer Vaccine Sales Market Share by Application (2017-2022)
    5.2 Global Dendritic Cell Cancer Vaccine Revenue Market Share by Application (2017-2022)
    5.3 Global Dendritic Cell Cancer Vaccine Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Activarti
        6.1.1 Activarti Corporation Information
        6.1.2 Activarti Description and Business Overview
        6.1.3 Activarti Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Activarti Dendritic Cell Cancer Vaccine Product Portfolio
        6.1.5 Activarti Recent Developments/Updates
    6.2 Argos Therapeutics
        6.2.1 Argos Therapeutics Corporation Information
        6.2.2 Argos Therapeutics Description and Business Overview
        6.2.3 Argos Therapeutics Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Argos Therapeutics Dendritic Cell Cancer Vaccine Product Portfolio
        6.2.5 Argos Therapeutics Recent Developments/Updates
    6.3 SOTIO (Acquired by PPF Group)
        6.3.1 SOTIO (Acquired by PPF Group) Corporation Information
        6.3.2 SOTIO (Acquired by PPF Group) Description and Business Overview
        6.3.3 SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Product Portfolio
        6.3.5 SOTIO (Acquired by PPF Group) Recent Developments/Updates
    6.4 Bellicum Pharmaceuticals
        6.4.1 Bellicum Pharmaceuticals Corporation Information
        6.4.2 Bellicum Pharmaceuticals Description and Business Overview
        6.4.3 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Product Portfolio
        6.4.5 Bellicum Pharmaceuticals Recent Developments/Updates
    6.5 JW CreaGene
        6.5.1 JW CreaGene Corporation Information
        6.5.2 JW CreaGene Description and Business Overview
        6.5.3 JW CreaGene Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 JW CreaGene Dendritic Cell Cancer Vaccine Product Portfolio
        6.5.5 JW CreaGene Recent Developments/Updates
    6.6 DanDrit
        6.6.1 DanDrit Corporation Information
        6.6.2 DanDrit Description and Business Overview
        6.6.3 DanDrit Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 DanDrit Dendritic Cell Cancer Vaccine Product Portfolio
        6.6.5 DanDrit Recent Developments/Updates
    6.7 DCPrime
        6.6.1 DCPrime Corporation Information
        6.6.2 DCPrime Description and Business Overview
        6.6.3 DCPrime Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 DCPrime Dendritic Cell Cancer Vaccine Product Portfolio
        6.7.5 DCPrime Recent Developments/Updates
    6.8 Elios Therapeutics
        6.8.1 Elios Therapeutics Corporation Information
        6.8.2 Elios Therapeutics Description and Business Overview
        6.8.3 Elios Therapeutics Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Elios Therapeutics Dendritic Cell Cancer Vaccine Product Portfolio
        6.8.5 Elios Therapeutics Recent Developments/Updates
    6.9 ImmunoCellular Therapeutics
        6.9.1 ImmunoCellular Therapeutics Corporation Information
        6.9.2 ImmunoCellular Therapeutics Description and Business Overview
        6.9.3 ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Product Portfolio
        6.9.5 ImmunoCellular Therapeutics Recent Developments/Updates
    6.10 Kiromic
        6.10.1 Kiromic Corporation Information
        6.10.2 Kiromic Description and Business Overview
        6.10.3 Kiromic Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Kiromic Dendritic Cell Cancer Vaccine Product Portfolio
        6.10.5 Kiromic Recent Developments/Updates
    6.11 Medigene
        6.11.1 Medigene Corporation Information
        6.11.2 Medigene Dendritic Cell Cancer Vaccine Description and Business Overview
        6.11.3 Medigene Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 Medigene Dendritic Cell Cancer Vaccine Product Portfolio
        6.11.5 Medigene Recent Developments/Updates
    6.12 Merck
        6.12.1 Merck Corporation Information
        6.12.2 Merck Dendritic Cell Cancer Vaccine Description and Business Overview
        6.12.3 Merck Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 Merck Dendritic Cell Cancer Vaccine Product Portfolio
        6.12.5 Merck Recent Developments/Updates
    6.13 Northwest Biotherapeutics
        6.13.1 Northwest Biotherapeutics Corporation Information
        6.13.2 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Description and Business Overview
        6.13.3 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Product Portfolio
        6.13.5 Northwest Biotherapeutics Recent Developments/Updates
    6.14 Immutep Limited
        6.14.1 Immutep Limited Corporation Information
        6.14.2 Immutep Limited Dendritic Cell Cancer Vaccine Description and Business Overview
        6.14.3 Immutep Limited Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.14.4 Immutep Limited Dendritic Cell Cancer Vaccine Product Portfolio
        6.14.5 Immutep Limited Recent Developments/Updates
    6.15 Dendreon Corporation
        6.15.1 Dendreon Corporation Corporation Information
        6.15.2 Dendreon Corporation Dendritic Cell Cancer Vaccine Description and Business Overview
        6.15.3 Dendreon Corporation Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.15.4 Dendreon Corporation Dendritic Cell Cancer Vaccine Product Portfolio
        6.15.5 Dendreon Corporation Recent Developments/Updates
    6.16 Oncobiomed
        6.16.1 Oncobiomed Corporation Information
        6.16.2 Oncobiomed Dendritic Cell Cancer Vaccine Description and Business Overview
        6.16.3 Oncobiomed Dendritic Cell Cancer Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.16.4 Oncobiomed Dendritic Cell Cancer Vaccine Product Portfolio
        6.16.5 Oncobiomed Recent Developments/Updates
7 Dendritic Cell Cancer Vaccine Manufacturing Cost Analysis
    7.1 Dendritic Cell Cancer Vaccine Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Dendritic Cell Cancer Vaccine
    7.4 Dendritic Cell Cancer Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Dendritic Cell Cancer Vaccine Distributors List
    8.3 Dendritic Cell Cancer Vaccine Customers
9 Dendritic Cell Cancer Vaccine Market Dynamics
    9.1 Dendritic Cell Cancer Vaccine Industry Trends
    9.2 Dendritic Cell Cancer Vaccine Market Drivers
    9.3 Dendritic Cell Cancer Vaccine Market Challenges
    9.4 Dendritic Cell Cancer Vaccine Market Restraints
10 Global Market Forecast
    10.1 Dendritic Cell Cancer Vaccine Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Dendritic Cell Cancer Vaccine by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Dendritic Cell Cancer Vaccine by Type (2023-2028)
    10.2 Dendritic Cell Cancer Vaccine Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Dendritic Cell Cancer Vaccine by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Dendritic Cell Cancer Vaccine by Application (2023-2028)
    10.3 Dendritic Cell Cancer Vaccine Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Dendritic Cell Cancer Vaccine by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Dendritic Cell Cancer Vaccine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Dendritic Cell Cancer Vaccine Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Dendritic Cell Cancer Vaccine Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Dendritic Cell Cancer Vaccine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Dendritic Cell Cancer Vaccine Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Dendritic Cell Cancer Vaccine Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Dendritic Cell Cancer Vaccine Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Dendritic Cell Cancer Vaccine Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Dendritic Cell Cancer Vaccine Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Dendritic Cell Cancer Vaccine Average Price (USD/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Dendritic Cell Cancer Vaccine Manufacturing Sites and Area Served
    Table 11. Manufacturers Dendritic Cell Cancer Vaccine Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Dendritic Cell Cancer Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dendritic Cell Cancer Vaccine as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Dendritic Cell Cancer Vaccine Sales by Region (2017-2022) & (K Units)
    Table 16. Global Dendritic Cell Cancer Vaccine Sales Market Share by Region (2017-2022)
    Table 17. Global Dendritic Cell Cancer Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Region (2017-2022)
    Table 19. North America Dendritic Cell Cancer Vaccine Sales by Country (2017-2022) & (K Units)
    Table 20. North America Dendritic Cell Cancer Vaccine Sales Market Share by Country (2017-2022)
    Table 21. North America Dendritic Cell Cancer Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2017-2022)
    Table 23. Europe Dendritic Cell Cancer Vaccine Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Dendritic Cell Cancer Vaccine Sales Market Share by Country (2017-2022)
    Table 25. Europe Dendritic Cell Cancer Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Dendritic Cell Cancer Vaccine Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Dendritic Cell Cancer Vaccine Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Dendritic Cell Cancer Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Dendritic Cell Cancer Vaccine Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Dendritic Cell Cancer Vaccine Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Dendritic Cell Cancer Vaccine Sales Market Share by Country (2017-2022)
    Table 33. Latin America Dendritic Cell Cancer Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Dendritic Cell Cancer Vaccine Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Dendritic Cell Cancer Vaccine Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Dendritic Cell Cancer Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Dendritic Cell Cancer Vaccine Revenue Market Share by Country (2017-2022)
    Table 39. Global Dendritic Cell Cancer Vaccine Sales by Type (2017-2022) & (K Units)
    Table 40. Global Dendritic Cell Cancer Vaccine Sales Market Share by Type (2017-2022)
    Table 41. Global Dendritic Cell Cancer Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Dendritic Cell Cancer Vaccine Revenue Share by Type (2017-2022)
    Table 43. Global Dendritic Cell Cancer Vaccine Price by Type (2017-2022) & (USD/Unit)
    Table 44. Global Dendritic Cell Cancer Vaccine Sales (K Units) by Application (2017-2022)
    Table 45. Global Dendritic Cell Cancer Vaccine Sales Market Share by Application (2017-2022)
    Table 46. Global Dendritic Cell Cancer Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Dendritic Cell Cancer Vaccine Revenue Share by Application (2017-2022)
    Table 48. Global Dendritic Cell Cancer Vaccine Price by Application (2017-2022) & (USD/Unit)
    Table 49. Activarti Corporation Information
    Table 50. Activarti Description and Business Overview
    Table 51. Activarti Dendritic Cell Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 52. Activarti Dendritic Cell Cancer Vaccine Product
    Table 53. Activarti Recent Developments/Updates
    Table 54. Argos Therapeutics Corporation Information
    Table 55. Argos Therapeutics Description and Business Overview
    Table 56. Argos Therapeutics Dendritic Cell Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 57. Argos Therapeutics Dendritic Cell Cancer Vaccine Product
    Table 58. Argos Therapeutics Recent Developments/Updates
    Table 59. SOTIO (Acquired by PPF Group) Corporation Information
    Table 60. SOTIO (Acquired by PPF Group) Description and Business Overview
    Table 61. SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 62. SOTIO (Acquired by PPF Group) Dendritic Cell Cancer Vaccine Product
    Table 63. SOTIO (Acquired by PPF Group) Recent Developments/Updates
    Table 64. Bellicum Pharmaceuticals Corporation Information
    Table 65. Bellicum Pharmaceuticals Description and Business Overview
    Table 66. Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 67. Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Product
    Table 68. Bellicum Pharmaceuticals Recent Developments/Updates
    Table 69. JW CreaGene Corporation Information
    Table 70. JW CreaGene Description and Business Overview
    Table 71. JW CreaGene Dendritic Cell Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 72. JW CreaGene Dendritic Cell Cancer Vaccine Product
    Table 73. JW CreaGene Recent Developments/Updates
    Table 74. DanDrit Corporation Information
    Table 75. DanDrit Description and Business Overview
    Table 76. DanDrit Dendritic Cell Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 77. DanDrit Dendritic Cell Cancer Vaccine Product
    Table 78. DanDrit Recent Developments/Updates
    Table 79. DCPrime Corporation Information
    Table 80. DCPrime Description and Business Overview
    Table 81. DCPrime Dendritic Cell Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 82. DCPrime Dendritic Cell Cancer Vaccine Product
    Table 83. DCPrime Recent Developments/Updates
    Table 84. Elios Therapeutics Corporation Information
    Table 85. Elios Therapeutics Description and Business Overview
    Table 86. Elios Therapeutics Dendritic Cell Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 87. Elios Therapeutics Dendritic Cell Cancer Vaccine Product
    Table 88. Elios Therapeutics Recent Developments/Updates
    Table 89. ImmunoCellular Therapeutics Corporation Information
    Table 90. ImmunoCellular Therapeutics Description and Business Overview
    Table 91. ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 92. ImmunoCellular Therapeutics Dendritic Cell Cancer Vaccine Product
    Table 93. ImmunoCellular Therapeutics Recent Developments/Updates
    Table 94. Kiromic Corporation Information
    Table 95. Kiromic Description and Business Overview
    Table 96. Kiromic Dendritic Cell Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 97. Kiromic Dendritic Cell Cancer Vaccine Product
    Table 98. Kiromic Recent Developments/Updates
    Table 99. Medigene Corporation Information
    Table 100. Medigene Description and Business Overview
    Table 101. Medigene Dendritic Cell Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 102. Medigene Dendritic Cell Cancer Vaccine Product
    Table 103. Medigene Recent Developments/Updates
    Table 104. Merck Corporation Information
    Table 105. Merck Description and Business Overview
    Table 106. Merck Dendritic Cell Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 107. Merck Dendritic Cell Cancer Vaccine Product
    Table 108. Merck Recent Developments/Updates
    Table 109. Northwest Biotherapeutics Corporation Information
    Table 110. Northwest Biotherapeutics Description and Business Overview
    Table 111. Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 112. Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Product
    Table 113. Northwest Biotherapeutics Recent Developments/Updates
    Table 114. Immutep Limited Corporation Information
    Table 115. Immutep Limited Description and Business Overview
    Table 116. Immutep Limited Dendritic Cell Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 117. Immutep Limited Dendritic Cell Cancer Vaccine Product
    Table 118. Immutep Limited Recent Developments/Updates
    Table 119. Dendreon Corporation Corporation Information
    Table 120. Dendreon Corporation Description and Business Overview
    Table 121. Dendreon Corporation Dendritic Cell Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 122. Dendreon Corporation Dendritic Cell Cancer Vaccine Product
    Table 123. Dendreon Corporation Recent Developments/Updates
    Table 124. Oncobiomed Corporation Information
    Table 125. Oncobiomed Description and Business Overview
    Table 126. Oncobiomed Dendritic Cell Cancer Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 127. Oncobiomed Dendritic Cell Cancer Vaccine Product
    Table 128. Oncobiomed Recent Developments/Updates
    Table 129. Production Base and Market Concentration Rate of Raw Material
    Table 130. Key Suppliers of Raw Materials
    Table 131. Dendritic Cell Cancer Vaccine Distributors List
    Table 132. Dendritic Cell Cancer Vaccine Customers List
    Table 133. Dendritic Cell Cancer Vaccine Market Trends
    Table 134. Dendritic Cell Cancer Vaccine Market Drivers
    Table 135. Dendritic Cell Cancer Vaccine Market Challenges
    Table 136. Dendritic Cell Cancer Vaccine Market Restraints
    Table 137. Global Dendritic Cell Cancer Vaccine Sales Forecast by Type (2023-2028) & (K Units)
    Table 138. Global Dendritic Cell Cancer Vaccine Sales Market Share Forecast by Type (2023-2028)
    Table 139. Global Dendritic Cell Cancer Vaccine Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 140. Global Dendritic Cell Cancer Vaccine Revenue Market Share Forecast by Type (2023-2028)
    Table 141. Global Dendritic Cell Cancer Vaccine Sales Forecast by Application (2023-2028) & (K Units)
    Table 142. Global Dendritic Cell Cancer Vaccine Sales Market Share Forecast by Application (2023-2028)
    Table 143. Global Dendritic Cell Cancer Vaccine Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 144. Global Dendritic Cell Cancer Vaccine Revenue Market Share Forecast by Application (2023-2028)
    Table 145. Global Dendritic Cell Cancer Vaccine Sales Forecast by Region (2023-2028) & (K Units)
    Table 146. Global Dendritic Cell Cancer Vaccine Sales Market Share Forecast by Region (2023-2028)
    Table 147. Global Dendritic Cell Cancer Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 148. Global Dendritic Cell Cancer Vaccine Revenue Market Share Forecast by Region (2023-2028)
    Table 149. Research Programs/Design for This Report
    Table 150. Key Data Information from Secondary Sources
    Table 151. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Dendritic Cell Cancer Vaccine
    Figure 2. Global Dendritic Cell Cancer Vaccine Market Share by Type in 2021 & 2028
    Figure 3. CreaVax Product Picture
    Figure 4. Sipuleucel-T (Provenge) Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Dendritic Cell Cancer Vaccine Market Share by Application in 2021 & 2028
    Figure 7. Pediatrics
    Figure 8. Adults
    Figure 9. Global Dendritic Cell Cancer Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Dendritic Cell Cancer Vaccine Market Size (2017-2028) & (US$ Million)
    Figure 11. Global Dendritic Cell Cancer Vaccine Sales (2017-2028) & (K Units)
    Figure 12. Dendritic Cell Cancer Vaccine Sales Share by Manufacturers in 2021
    Figure 13. Global Dendritic Cell Cancer Vaccine Revenue Share by Manufacturers in 2021
    Figure 14. The Global 5 and 10 Largest Dendritic Cell Cancer Vaccine Players: Market Share by Revenue in 2021
    Figure 15. Dendritic Cell Cancer Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 16. Global Dendritic Cell Cancer Vaccine Sales Market Share by Region (2017-2022)
    Figure 17. Global Dendritic Cell Cancer Vaccine Sales Market Share by Region in 2021
    Figure 18. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Region (2017-2022)
    Figure 19. Global Dendritic Cell Cancer Vaccine Revenue Market Share by Region in 2021
    Figure 20. U.S. Dendritic Cell Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 21. Canada Dendritic Cell Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. Germany Dendritic Cell Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. France Dendritic Cell Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. U.K. Dendritic Cell Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Italy Dendritic Cell Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Russia Dendritic Cell Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. China Dendritic Cell Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Japan Dendritic Cell Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. South Korea Dendritic Cell Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. India Dendritic Cell Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Australia Dendritic Cell Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Taiwan Dendritic Cell Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Indonesia Dendritic Cell Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Thailand Dendritic Cell Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Malaysia Dendritic Cell Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Philippines Dendritic Cell Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Vietnam Dendritic Cell Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Mexico Dendritic Cell Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Brazil Dendritic Cell Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Argentina Dendritic Cell Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Turkey Dendritic Cell Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Saudi Arabia Dendritic Cell Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. U.A.E Dendritic Cell Cancer Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Sales Market Share of Dendritic Cell Cancer Vaccine by Type (2017-2022)
    Figure 45. Manufacturing Cost Structure of Dendritic Cell Cancer Vaccine
    Figure 46. Manufacturing Process Analysis of Dendritic Cell Cancer Vaccine
    Figure 47. Dendritic Cell Cancer Vaccine Industrial Chain Analysis
    Figure 48. Channels of Distribution
    Figure 49. Distributors Profiles
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation
    Figure 52. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Activarti
Argos Therapeutics
SOTIO (Acquired by PPF Group)
Bellicum Pharmaceuticals
JW CreaGene
DanDrit
DCPrime
Elios Therapeutics
ImmunoCellular Therapeutics
Kiromic
Medigene
Merck
Northwest Biotherapeutics
Immutep Limited
Dendreon Corporation
Oncobiomed
Frequently Asked Questions
Dendritic Cell Cancer Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Dendritic Cell Cancer Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Dendritic Cell Cancer Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Dental 3D Scanners

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Dental Bonding Agent

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More